APO-METHYLPHENIDATE
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of APO-METHYLPHENIDATE in Canada?
Yes. APO-METHYLPHENIDATE 5MG has an active shortage reported to Health Canada (last updated October 2, 2026).
Why is APO-METHYLPHENIDATE not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will APO-METHYLPHENIDATE be available again?
The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Other Products
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
PHL-METHYLPHENIDATE
PHARMEL INC
METHYLPHENIDATE TAB 10MG
TECHNILAB PHARMA INC.
RATIO-METHYLPHENIDATE
TEVA CANADA LIMITED
METHYLPHENIDATE TAB 20MG
TECHNILAB PHARMA INC.
AA-METHYLPHENIDATE SR
Extended-ReleaseAA PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-10-16
~11 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02273950
Strength
5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Tier
Unrated
Last Updated
2026-10-02
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178